meta_pixel
Tapesearch Logo
Log in
Barron's Streetwise

Good News on Covid Treatments. And What's the Deal With Dave Portnoy?

Barron's Streetwise

Barron's

Business

4.71.6K Ratings

🗓️ 19 June 2020

⏱️ 20 minutes

🧾️ Download transcript

Summary

Jack talks with Gilead Sciences CEO Daniel O'Day, and weighs in on a day-trading celebrity. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

AI may be the most important new computer technology ever, but AI needs a lot of

0:06.4

processing speed and that gets expensive fast.

0:09.6

Upgrade to the next generation of the cloud, Oracle Cloud Infrastructure, or OCI.

0:16.0

OCI is the single platform for your infrastructure, database, application development, and AI needs.

0:23.0

See how customers like Uber and Cohere

0:26.0

are training their AI models at twice the speed and less than half the cost.

0:31.0

Take a free test drive of OC.C. I at Oracle.com

0:34.4

slash Wall Street.

0:35.8

That's Oracle.com slash Wall Street.

0:38.9

We knew fairly early on that it had a strong effect in the lab, but we had no idea if that would have a clinical effect in patients.

0:49.0

And so we immediately said, well, we have to be ready.

0:52.0

So we have to invest in this.

0:56.1

Welcome to the Barron Streetwise podcast. I'm Jack Howe. The voice you just heard, that's

1:01.5

Daniel O'Day.

1:02.8

He's the CEO of a drug company called Gilead Sciences,

1:06.8

best known for Remdesivere, an early leader in the race to treat COVID-19.

1:12.2

In a moment, we'll hear more from Dan and get an update on how quickly

1:16.3

more and better medicines might be available and when to expect life to get back to normal.

1:22.1

Listening in as always is our audio producer Meta, hi Meta.

1:26.0

Hey there.

1:27.0

Which would you like to do first?

1:29.0

Do you want to hear me struggle to pronounce some drug names or would you like to do a listener question?

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Barron's, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Barron's and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.